Control of feeding and sexual behaviors by neuropeptide Y: physiological implications.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 3212671)

Published in Synapse on January 01, 1988

Authors

S P Kalra1, J T Clark, A Sahu, M G Dube, P S Kalra

Author Affiliations

1: Department of Obstetrics and Gynecology, University of Florida College of Medicine, Gainesville 32610.

Articles by these authors

Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev (1999) 3.07

Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology (1984) 2.89

Effects of an intraoperative infusion of 4% succinylated gelatine (Gelofusine(R)) and 6% hydroxyethyl starch (Voluven(R)) on blood volume. Br J Anaesth (2012) 2.63

Structural and antigenic polymorphism of the 35- to 48-kilodalton merozoite surface antigen (MSA-2) of the malaria parasite Plasmodium falciparum. Mol Cell Biol (1991) 1.68

Problems with solutions: drowning in the brine of an inadequate knowledge base. Clin Nutr (2001) 1.67

Immunocytochemical differentiation of microtubules in the cytoskeleton of Giardia lamblia using monoclonal antibodies to alpha-tubulin and polyclonal antibodies to associated low molecular weight proteins. J Cell Sci (1986) 1.55

Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc Natl Acad Sci U S A (1991) 1.49

In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC. J Exp Med (1999) 1.46

Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting. Proc Natl Acad Sci U S A (1999) 1.42

Improving the success of nipple reconstruction. Ann R Coll Surg Engl (2011) 1.39

Neuropeptide Y stimulates feeding but inhibits sexual behavior in rats. Endocrinology (1985) 1.28

NPY and cohorts in regulating appetite, obesity and metabolic syndrome: beneficial effects of gene therapy. Neuropeptides (2004) 1.27

Mechanism of complement inactivation by glycoprotein C of herpes simplex virus. J Immunol (1997) 1.22

Topography of epitopes on a polymorphic schizont antigen of Plasmodium falciparum determined by the binding of monoclonal antibodies in a two-site radioimmunoassay. Parasite Immunol (1987) 1.19

Food intake elicited by central administration of orexins/hypocretins: identification of hypothalamic sites of action. Brain Res (1999) 1.17

Food deprivation and ingestion induce reciprocal changes in neuropeptide Y concentrations in the paraventricular nucleus. Peptides (1988) 1.17

Solution structure of Compstatin, a potent complement inhibitor. Protein Sci (1998) 1.15

Kinetic analysis of the interactions of complement receptor 2 (CR2, CD21) with its ligands C3d, iC3b, and the EBV glycoprotein gp350/220. J Immunol (2001) 1.12

Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation. Blood (1998) 1.11

Serum levels of sex hormones in vulvar lichen sclerosus, and the effect of topical testosterone. N Engl J Med (1984) 1.09

Central leptin gene therapy suppresses body weight gain, adiposity and serum insulin without affecting food consumption in normal rats: a long-term study. Regul Pept (2001) 1.08

Peri-operative fluid and electrolyte management: a survey of consultant surgeons in the UK. Ann R Coll Surg Engl (2002) 1.07

Orexins, a novel family of hypothalamic neuropeptides, modulate pituitary luteinizing hormone secretion in an ovarian steroid-dependent manner. Regul Pept (1998) 1.06

Neuropeptide Y: A hypothalamic brake restraining the onset of puberty in primates. Proc Natl Acad Sci U S A (2000) 1.06

Inhibition of heparin/protamine complex-induced complement activation by Compstatin in baboons. Clin Immunol (2000) 1.06

Body mass influences cortical bone mass independent of leptin signaling. Bone (2008) 1.03

Neural regulation of luteinizing hormone secretion in the rat. Endocr Rev (1983) 1.02

Dose-dependent effects of central leptin gene therapy on genes that regulate body weight and appetite in the hypothalamus. Mol Ther (2001) 1.01

Effects of orchidectomy on levels of the mRNAs encoding gonadotropin-releasing hormone and other hypothalamic peptides in the adult male rhesus monkey (Macaca mulatta). J Neuroendocrinol (2000) 1.01

Interactions between neuropeptide Y and gamma-aminobutyric acid in stimulation of feeding: a morphological and pharmacological analysis. Endocrinology (1999) 1.00

Anorectic effects of the cytokine, ciliary neurotropic factor, are mediated by hypothalamic neuropeptide Y: comparison with leptin. Endocrinology (1998) 0.99

Perceptions of blindness related to smoking: a hospital-based cross-sectional study. Eye (Lond) (2005) 0.99

Leptin resistance of adipocytes in obesity: role of suppressors of cytokine signaling. Biochem Biophys Res Commun (2000) 0.99

Polymorphism of a 35-48 kDa Plasmodium falciparum merozoite surface antigen. Mol Biochem Parasitol (1989) 0.99

Neuropeptide Y (NPY)-induced feeding behavior in female rats: comparison with human NPY ([Met17]NPY), NPY analog ([norLeu4]NPY) and peptide YY. Regul Pept (1987) 0.99

Anorectic effects of estrogen may be mediated by decreased neuropeptide-Y release in the hypothalamic paraventricular nucleus. Endocrinology (1994) 0.98

Compstatin, a peptide inhibitor of C3, prolongs survival of ex vivo perfused pig xenografts. Xenotransplantation (1999) 0.97

Neuropeptide Y stimulates feeding but inhibits sexual behavior in rats. 1985. Obes Res (1997) 0.97

Central nervous system receptors involved in mediating the inhibitory action of neuropeptide Y on luteinizing hormone secretion in the male rhesus monkey (Macaca mulatta). J Neuroendocrinol (2003) 0.96

Daily changes in hypothalamic gene expression of neuropeptide Y, galanin, proopiomelanocortin, and adipocyte leptin gene expression and secretion: effects of food restriction. Endocrinology (1999) 0.95

Evidence for the existence of distinct central appetite, energy expenditure, and ghrelin stimulation pathways as revealed by hypothalamic site-specific leptin gene therapy. Endocrinology (2002) 0.95

Evidence that NPY-containing neurons in the brainstem project into selected hypothalamic nuclei: implication in feeding behavior. Brain Res (1988) 0.95

Neuropeptide Y: a novel neuroendocrine peptide in the control of pituitary hormone secretion, and its relation to luteinizing hormone. Front Neuroendocrinol (1992) 0.95

Localization of neuropeptide-Y immunoreactivity in estradiol-concentrating cells in the hypothalamus. Endocrinology (1990) 0.94

Neuropeptide-Y concentration in microdissected hypothalamic regions and in vitro release from the medial basal hypothalamus-preoptic area of streptozotocin-diabetic rats with and without insulin substitution therapy. Endocrinology (1990) 0.94

Evidence of a physiological role for neuropeptide Y in ventromedial hypothalamic lesion-induced hyperphagia. Brain Res (1995) 0.94

Changes in hypothalamic gene expression associated with the arrest of pulsatile gonadotropin-releasing hormone release during infancy in the agonadal male rhesus monkey (Macaca mulatta). Endocrinology (2000) 0.94

Ovarian-pituitary hormone interactions during the perimenopause. Maturitas (1989) 0.94

Enhancement of sexual motivation in male rats by yohimbine. Science (1984) 0.92

Nutritional infertility: the role of the interconnected hypothalamic neuropeptide Y-galanin-opioid network. Front Neuroendocrinol (1996) 0.91

Diverse effects of tachykinins on luteinizing hormone release in male rats: mechanism of action. Endocrinology (1992) 0.91

Participation of the amygdala and of the cerebellum in the feedback effects of progesterone. Neuroendocrinology (1973) 0.91

The effect of trainee involvement on procedure and list times: A statistical analysis with discussion of current issues affecting orthopaedic training in UK. Surgeon (2010) 0.91

Long-term differential modulation of genes encoding orexigenic and anorexigenic peptides by leptin delivered by rAAV vector in ob/ob mice. Relationship with body weight change. Regul Pept (2000) 0.90

Plasma membrane isolated from Giardia lamblia: identification of membrane proteins. Eur J Cell Biol (1986) 0.90

Agmatine, a novel hypothalamic amine, stimulates pituitary luteinizing hormone release in vivo and hypothalamic luteinizing hormone-releasing hormone release in vitro. Neurosci Lett (1995) 0.90

Neuropeptide Y counteracts the anorectic and weight reducing effects of ciliary neurotropic factor. J Neuroendocrinol (2000) 0.90

Interleukin-1 inhibits the ovarian steroid-induced luteinizing hormone surge and release of hypothalamic luteinizing hormone-releasing hormone in rats. Endocrinology (1990) 0.90

Hormones and sexual behavior in relationship to aging in male rats. Horm Behav (1992) 0.89

Inhibition of neuropeptide Y (NPY)-induced feeding and c-Fos response in magnocellular paraventricular nucleus by a NPY receptor antagonist: a site of NPY action. Endocrinology (1999) 0.88

Disruption in neuropeptide Y and leptin signaling in obese ventromedial hypothalamic-lesioned rats. Brain Res (1999) 0.88

Ovarian regulation of kisspeptin neurones in the arcuate nucleus of the rhesus monkey (macaca mulatta). J Neuroendocrinol (2013) 0.88

Leptin and ciliary neurotropic factor (CNTF) inhibit fasting-induced suppression of luteinizing hormone release in rats: role of neuropeptide Y. Neurosci Lett (1998) 0.88

Morphometric analysis of CC10-hASH1 transgenic mouse lung: a model for bronchiolization of alveoli and neuroendocrine carcinoma. Exp Lung Res (2000) 0.88

Prolongation of ex vivo-perfused pig xenograft survival by the complement inhibitor Compstatin. Transplant Proc (1999) 0.87

Bilateral neural transections at the level of mesencephalon increase food intake and reduce latency to onset of feeding in response to neuropeptide Y. Peptides (1989) 0.87

Opioid-adrenergic-steroid connection in regulation of luteinizing hormone secretion in the rat. Neuroendocrinology (1984) 0.87

Resistance to adenovirally induced hyperleptinemia in rats. Comparison of ventromedial hypothalamic lesions and mutated leptin receptors. J Clin Invest (1998) 0.87

Temporal interrelationships among circulating levels of estradiol, progesterone and LH during the rat estrous cycle: effects of exogenous progesterone. Endocrinology (1974) 0.87

Insulin and insulin-like growth factor II suppress neuropeptide Y release from the nerve terminals in the paraventricular nucleus: a putative hypothalamic site for energy homeostasis. Endocrinology (1995) 0.87

The morphine-prostigmine provocation (Nardi) test for sphincter of Oddi dysfunction: results in healthy volunteers and in patients before and after transduodenal sphincteroplasty and transampullary septectomy. Gut (2007) 0.87

Multiple forms of complement C3 in trout that differ in binding to complement activators. Proc Natl Acad Sci U S A (1996) 0.86

Do testosterone and estradiol-17 beta enforce inhibition or stimulation of luteinizing hormone-releasing hormone secretion? Biol Reprod (1989) 0.85

Neuropeptide Y release is elevated from the microdissected paraventricular nucleus of food-deprived rats: an in vitro study. Endocrinology (1992) 0.85

Evidence that neuropeptide Y is a physiological signal for normal food intake. Brain Res (1994) 0.85

Distribution of cytoplasmic estrogen and progesterone receptors in human endometrium. Am J Obstet Gynecol (1978) 0.84

Evidence that nitric oxide may mediate the ovarian steroid-induced luteinizing hormone surge: involvement of excitatory amino acids. Endocrinology (1993) 0.84

Opioid peptides in pseudocyesis. Obstet Gynecol (1985) 0.84

Neuropeptide Y release from the paraventricular nucleus increases in association with hyperphagia in streptozotocin-induced diabetic rats. Endocrinology (1992) 0.84